Detalles de la búsqueda
1.
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.
Lancet Oncol
; 25(6): e270-e280, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821101
2.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697165
3.
A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.
BMC Cancer
; 24(1): 333, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38475762
4.
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".
World J Urol
; 42(1): 169, 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492078
5.
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models.
Eur Radiol
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38507053
6.
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi).
Int J Gynecol Cancer
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821546
7.
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
Radiol Med
; 129(1): 160-173, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731151
8.
Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?
Radiol Med
; 129(2): 328-334, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280971
9.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Lancet Oncol
; 24(3): e121-e132, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858728
10.
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study.
BMC Cancer
; 23(1): 1236, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102575
11.
Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey.
Eur Radiol
; 33(10): 6736-6745, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071161
12.
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Int J Colorectal Dis
; 38(1): 123, 2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162567
13.
Quality of life changes over time and predictors in a large head and neck patients' cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study-a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
Support Care Cancer
; 31(4): 220, 2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930353
14.
Comparison of automated segmentation techniques for magnetic resonance images of the prostate.
BMC Med Imaging
; 23(1): 32, 2023 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774463
15.
The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors.
Oral Dis
; 29(1): 128-137, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33893695
16.
What is the best time for postoperative radiation therapy in pN1 prostate cancer?
Neoplasma
; 70(3): 458-467, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37498071
17.
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations.
Radiol Med
; 128(8): 1007-1021, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415056
18.
A narrative review for radiation oncologists to implement preoperative partial breast irradiation.
Radiol Med
; 128(12): 1553-1570, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650981
19.
Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma.
Contemp Oncol (Pozn)
; 27(1): 22-27, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37266336
20.
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature.
Breast Cancer Res Treat
; 192(2): 249-263, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025004